Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 49
Filter
1.
Phys Rev Lett ; 132(7): 076901, 2024 Feb 16.
Article in English | MEDLINE | ID: mdl-38427860

ABSTRACT

Orbital current has emerged over the past years as one of the key novel concepts in magnetotransport. Here, we demonstrate that laser pulses can be used to generate large and robust nonrelativistic orbital currents in systems where the inversion symmetry is broken by the orbital Rashba effect. By referring to model and first principles tools, we demonstrate that orbital Rashba effect, accompanied by crystal field splitting, can mediate robust orbital photocurrents without a need for spin-orbit interaction even in metallic systems. We show that such nonrelativistic orbital photocurrents are translated into derivative photocurrents of spin when relativistic effects are taken into account. We thus promote orbital photocurrents as a promising platform for optical generation of currents of angular momentum, and discuss their possible applications.

2.
J Comp Pathol ; 166: 1-4, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30691600

ABSTRACT

A 9-year-old neutered male Shih Tzu was presented with three contiguous firm nodules in the subcutaneous tissue of the interscapular region. Histopathological examination revealed that the nodules consisted of mature lamellar bone with a Haversian system, with no apparent lesion around the bone. Clinical examination revealed that the dog had no underlying disease and no history of trauma at the lesion site. Based on these findings and on the medical history, a diagnosis of primary osteoma cutis was made. Osteoma cutis is rare in both human and veterinary medicine, and most dogs reported to have secondary osteoma cutis. To our knowledge, this case is only the second report of primary osteoma cutis in a dog.


Subject(s)
Bone Diseases, Metabolic/veterinary , Dog Diseases/pathology , Ossification, Heterotopic/veterinary , Skin Diseases, Genetic/veterinary , Animals , Dogs , Male
3.
Lupus ; 27(10): 1600-1615, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29958502

ABSTRACT

Lupus nephritis (LN) is a major complication of systemic lupus erythematosus (SLE). Conventional biomarkers for assessing renal disease activity are imperfect in predicting clinical outcomes associated with LN. The aim of this study is to identify urinary protein biomarkers that reliably reflect the disease activity or predict clinical outcomes. A quantitative proteomic analysis was performed to identify protein biomarker candidates that can differentiate between SLE patients with and without LN. Selected biomarker candidates were further verified by enzyme-linked immunosorbent assay using urine samples from a larger cohort of SLE patients ( n = 121) to investigate their predictive values for LN activity measure. Furthermore, the association between urinary levels of a selected panel of potential biomarkers and prognosis of LN was assessed with a four-year follow-up study of renal outcomes. Urinary vitamin D-binding protein (VDBP), transthyretin (TTR), retinol binding protein 4 (RBP4), and prostaglandin D synthase (PTGDS) were significantly elevated in SLE patients with LN, especially in patients with active LN ( n = 21). Among them, VDBP well correlated with severity of proteinuria (rho = 0.661, p < 0.001) and renal SLE Disease Activity Index (renal SLEDAI) (rho = 0.520, p < 0.001). In the four-year follow-up, VDBP was a significant risk factor (hazard ratio 9.627, 95% confidence interval 1.698 to 54.571, p = 0.011) for the development of proteinuric flare in SLE patients without proteinuria ( n = 100) after adjustments for multiple confounders. Urinary VDBP correlated with proteinuria and renal SLEDAI, and predicted the development of proteinuria.


Subject(s)
Lupus Nephritis/diagnosis , Proteinuria/diagnosis , Vitamin D-Binding Protein/urine , Adult , Biomarkers/urine , Cross-Sectional Studies , Disease Progression , Enzyme-Linked Immunosorbent Assay , Female , Humans , Lupus Nephritis/therapy , Lupus Nephritis/urine , Male , Middle Aged , Predictive Value of Tests , Prognosis , Proteinuria/therapy , Proteinuria/urine , Proteomics/methods , Reproducibility of Results , Severity of Illness Index , Time Factors , Up-Regulation , Urinalysis , Young Adult
4.
Clin. transl. oncol. (Print) ; 20(6): 713-718, jun. 2018. ilus, tab, graf
Article in English | IBECS | ID: ibc-173619

ABSTRACT

Introduction: Hematologic toxicity (HT) in cervical cancer patients can cause treatment delays and reduction in chemotherapy, especially in high risk patients. Dose to PET-defined regions of active bone marrow (ABM) has been shown to correlate with cytopenias. An absolute volume of ABM spared may accurately represent hematopoietic reserve and risk of HT. This analysis evaluates whether the volume of ABM spared can more accurately predict HT compared to conventional dosimetric parameters. Methods: Thirty-one patients treated for cervical cancer with chemoradiation from 9/2011 to 8/2016 were retrospectively reviewed. Receiver operating characteristic (ROC) curve were used to assess optimal cutpoint criterions for grade 3+ HT based on the CTCAEv4. Conventional dosimetric parameters to PBM and ABM (mean dose, V10, V20, V40) were assessed as well as the absolute volume (cc) of PBM and ABM spared 10, 20, and 40 Gy. Results: The absolute volume of PBM spared 10 Gy (< 230 cc; AUC 0.732, p = 0.03) as well as volume of ABM spared 10 Gy (< 179 cc; AUC 0.815, p = 0.0002), spared 20 Gy (< 186 cc; AUC 0.774, p = 0.0015), and spared 40 Gy (< 738 cc; AUC 0.887, p < 0.0001) all predicted grade 3+ HT. In patients with < 738 cc of ABM spared 40 Gy, 18/18 (100%) had grade 3+ toxicity compared to 6/13 (46%) of patients with > 738 cc of ABM spared 40 Gy (p < 0.0001). Conclusion: The baseline volume of ABM and the fraction of ABM present in patients vary significantly. The ongoing NRG-GY006 trial and other efforts at bone marrow sparing use V10, V20, and mean dose to the ABM during planning optimization. This analysis suggests that the volume of ABM spared 40 Gy (> 738 cc) may be a stronger predictor of HT than conventional dosimetric parameters. This should be further evaluated for clinical use


No disponible


Subject(s)
Humans , Female , Adult , Middle Aged , Aged , Positron Emission Tomography Computed Tomography/methods , Uterine Cervical Neoplasms/therapy , Chemoradiotherapy/adverse effects , Toxicity Tests/methods , Radioisotopes/administration & dosage , Uterine Cervical Neoplasms/pathology , Bone Marrow , Bone Marrow/radiation effects , Retrospective Studies
5.
Am J Gastroenterol ; 113(5): 677-685, 2018 05.
Article in English | MEDLINE | ID: mdl-29681624

ABSTRACT

OBJECTIVES: Studies on the impact of rapid on-site evaluation (ROSE) during endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) of lymph nodes are retrospective and have shown conflicting results. We aimed to compare the diagnostic yield of EUS-FNA of lymph nodes with ROSE (ROSE+) and without ROSE (ROSE-). METHODS: This was a multicenter, randomized controlled trial. Consecutive patients who were scheduled to undergo EUS-FNA of mediastinal or abdominal lymph nodes were randomized to ROSE+ or ROSE-. In the ROSE+ group, the number of passes was dictated by the on-site cytotechnician. In the ROSE- group, five passes were performed without interference from the cytotechnician. All samples were reviewed by a single-expert cytopathologist, blinded to group allocation. Primary endpoint was diagnostic yield with and without ROSE. RESULTS: After inclusion of 90 patients, interim analysis showed futility of study continuation since diagnostic yield of ROSE+ and ROSE- were comparable. A total of 91 patients were randomized to ROSE+ (N = 45) or ROSE- (N = 46). Diagnostic yield of ROSE+ and ROSE- and diagnostic accuracy were comparable: 93.3% vs. 95.7% (P = 0.68) and 97.6% vs. 93.2% (P = 0.62), respectively. Two major complications (one per group) occurred (p = 0.99). ROSE- patients more often reported self-limiting post-procedural pain (p < 0.001). Median procedure time for ROSE+ (20 min) and ROSE- (23 min) was comparable (P = 0.06). Median time to review slides in the ROSE- group (12:47 min) was longer than with ROSE+ (7:52 min) (P < 0.001). Mean costs of ROSE- and ROSE+ were comparable: €938.29 (±172.70) vs. €945.98 (±223.38) (P = 0.91), respectively. CONCLUSIONS: Diagnostic yield and accuracy of EUS-FNA of mediastinal and abdominal lymph nodes with and without ROSE are comparable. Time needed to review slides was shorter and post-procedural pain was less often reported in the ROSE+ group. Based on the primary outcome, the implementation of ROSE during EUS-FNA of mediastinal and abdominal lymph nodes cannot be advised. (Dutch Trial Register: NTR4876).


Subject(s)
Lymph Nodes/pathology , Lymphatic Metastasis/diagnosis , Pancreatic Neoplasms/pathology , Abdomen , Adult , Aged , Endoscopic Ultrasound-Guided Fine Needle Aspiration , Female , Humans , Lymphatic Metastasis/pathology , Male , Mediastinum , Middle Aged , Netherlands , Retrospective Studies , Time Factors
6.
Clin Transl Oncol ; 20(6): 713-718, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29076030

ABSTRACT

INTRODUCTION: Hematologic toxicity (HT) in cervical cancer patients can cause treatment delays and reduction in chemotherapy, especially in high risk patients. Dose to PET-defined regions of active bone marrow (ABM) has been shown to correlate with cytopenias. An absolute volume of ABM spared may accurately represent hematopoietic reserve and risk of HT. This analysis evaluates whether the volume of ABM spared can more accurately predict HT compared to conventional dosimetric parameters. METHODS: Thirty-one patients treated for cervical cancer with chemoradiation from 9/2011 to 8/2016 were retrospectively reviewed. Receiver operating characteristic (ROC) curve were used to assess optimal cutpoint criterions for grade 3+ HT based on the CTCAEv4. Conventional dosimetric parameters to PBM and ABM (mean dose, V10, V20, V40) were assessed as well as the absolute volume (cc) of PBM and ABM spared 10, 20, and 40 Gy. RESULTS: The absolute volume of PBM spared 10 Gy (< 230 cc; AUC 0.732, p = 0.03) as well as volume of ABM spared 10 Gy (< 179 cc; AUC 0.815, p = 0.0002), spared 20 Gy (< 186 cc; AUC 0.774, p = 0.0015), and spared 40 Gy (< 738 cc; AUC 0.887, p < 0.0001) all predicted grade 3+ HT. In patients with < 738 cc of ABM spared 40 Gy, 18/18 (100%) had grade 3+ toxicity compared to 6/13 (46%) of patients with > 738 cc of ABM spared 40 Gy (p < 0.0001). CONCLUSION: The baseline volume of ABM and the fraction of ABM present in patients vary significantly. The ongoing NRG-GY006 trial and other efforts at bone marrow sparing use V10, V20, and mean dose to the ABM during planning optimization. This analysis suggests that the volume of ABM spared 40 Gy (> 738 cc) may be a stronger predictor of HT than conventional dosimetric parameters. This should be further evaluated for clinical use.


Subject(s)
Bone Marrow/pathology , Chemoradiotherapy/adverse effects , Hematologic Diseases/diagnosis , Positron-Emission Tomography/methods , Uterine Cervical Neoplasms/therapy , Adult , Aged , Bone Marrow/diagnostic imaging , Bone Marrow/drug effects , Bone Marrow/radiation effects , Female , Follow-Up Studies , Hematologic Diseases/diagnostic imaging , Hematologic Diseases/etiology , Humans , Middle Aged , Prognosis , Retrospective Studies , Uterine Cervical Neoplasms/diagnostic imaging , Uterine Cervical Neoplasms/pathology
7.
J Comp Pathol ; 157(4): 296-298, 2017 Nov.
Article in English | MEDLINE | ID: mdl-29169626

ABSTRACT

A 12-year-old female miniature schnauzer and a 12-year-old neutered female cocker spaniel each had a grey-yellow nodular lesion arising from the gingiva. Microscopical examination showed that both nodules were composed of varied proportions of sebocytes and basal-type reserve cells with few ducts lined by stratified squamous epithelium. Based on the histopathological findings, the cases were diagnosed as sebaceous adenoma and sebaceous epithelioma, respectively. In man, the occurrence of sebaceous neoplasms in the oral cavity has been reported to some extent, but these lesions are very rare in animals. To the best of our knowledge, this is the first report of intra-oral sebaceous neoplasms in dogs. Intra-oral sebaceous epithelioma has never been reported in animals.


Subject(s)
Dog Diseases/pathology , Mouth Neoplasms/veterinary , Sebaceous Gland Neoplasms/veterinary , Animals , Dogs , Female
8.
J Comp Pathol ; 157(2-3): 215-219, 2017.
Article in English | MEDLINE | ID: mdl-28942306

ABSTRACT

A 1-year-old, female domestic shorthair cat was presented with anorexia, depression and weight loss, accompanied by multifocal nodules affecting the face, pinnae and periarticular tissue. Routine medical treatments were ineffective. The animal's physical condition continued to deteriorate and it finally died. Post-mortem examination revealed multifocal to coalescing firm nodules with occasional ulceration affecting the ears, peri-ocular areas, nasal planum, oral cavity and laryngopharyngeal region. Tan-coloured, firm, nodular lesions were also observed in the periarticular tissue, lungs and tracheobronchial and mediastinal lymph nodes. Impression smears of several of these lesions revealed a myriad of slender rod-shaped organisms, mainly in the cytoplasm of macrophages. Histopathological examination showed severe pyogranulomatous inflammation with or without necrosis in the nodules. Acid-fast staining revealed large numbers of acid-fast bacilli. Mycobacterium kansasii was detected in the tissues using multiplex polymerase chain reaction and DNA sequencing. No protozoal or fungal organisms were detected using special stains. On the basis of these results, the cat was diagnosed with systemic M. kansasii infection. To our knowledge, there have been few reports of M. kansasii infection, especially with systemic spread, in cats.


Subject(s)
Cat Diseases/microbiology , Mycobacterium Infections, Nontuberculous/veterinary , Animals , Cats , Female , Mycobacterium kansasii
9.
J Vet Intern Med ; 31(5): 1514-1519, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28782844

ABSTRACT

Hepatocutaneous syndrome (HS) is an uncommon skin disorder that occurs in conjunction with liver disease and is diagnosed based on decreased plasma concentrations of amino acids and the histopathology of skin lesions. The survival period generally is <6 months. A 10-year-old castrated male Maltese dog was presented for evaluation of lethargy, polyuria, polydipsia, and skin lesions including alopecia, erythema, and crusts. Based on increased liver enzyme activity, low plasma amino acid concentrations, and findings from liver cytology and skin biopsy, the dog was diagnosed with HS. In addition to administration of antioxidants, hepatoprotective agents, and amino acids IV, allogenic adipose tissue-derived mesenchymal stem cells were infused 46 times over a 30-month period: 8 times directly into the liver parenchyma guided by ultrasonography and the remainder of the times into peripheral veins. After commencing stem cell therapy, the dog's hair re-grew and the skin lesions disappeared or became smaller. During ongoing management, the patient suddenly presented with anorexia and uncontrolled vomiting, and severe azotemia was observed. The dog died despite intensive care. On necropsy, severe liver fibrosis and superficial necrolytic dermatitis were observed. The dog survived for 32 months after diagnosis. A combination of amino acid and stem cell therapy may be beneficial for patients with HS.


Subject(s)
Dog Diseases/therapy , Liver Diseases/veterinary , Skin Diseases/veterinary , Animals , Dog Diseases/pathology , Dogs , Liver/pathology , Liver Diseases/complications , Liver Diseases/pathology , Liver Diseases/therapy , Male , Mesenchymal Stem Cell Transplantation/veterinary , Skin/pathology , Skin Diseases/complications , Skin Diseases/pathology , Skin Diseases/therapy
10.
J Immunol Methods ; 434: 16-23, 2016 07.
Article in English | MEDLINE | ID: mdl-27084117

ABSTRACT

Current methods to determine cellular cytotoxicity in vitro are hampered by background signals that are caused by auto-fluorescent target and effector cells and by non-specific cell death. We combined and adjusted existing cell viability assays to develop a method that allows for highly reproducible, accurate, single cell analysis by high throughput FACS, in which non-specific cell death is corrected for. In this assay the number of living, calcein AM labeled cells that are green fluorescent are quantified by adding a fixed number of unlabeled calibration beads to the analysis. Using this modified FACS calcein AM retention method, we found EC50 values to be highly reproducible and considerably lower compared to EC50 values obtained by conventional assays, displaying the high sensitivity of this assay.


Subject(s)
Cytotoxicity, Immunologic , Flow Cytometry/methods , Fluoresceins/chemistry , Killer Cells, Natural/immunology , Biological Assay , Cell Line, Tumor , Cell Survival , Fluorescent Dyes/chemistry , Humans , Rituximab/chemistry , Trastuzumab/chemistry , Tumor Cells, Cultured
11.
Curr Mol Med ; 16(4): 343-52, 2016.
Article in English | MEDLINE | ID: mdl-26980700

ABSTRACT

There has been prolonged and significant interest in manipulating the genome for a wide range of applications in biomedical research and medicine. An existing challenge in realizing this potential has been the inability to precisely edit specific DNA sequences. Past efforts to generate targeted double stranded DNA cleavage have fused DNA-targeting elements such as zinc fingers and DNA-binding proteins to endonucleases. However, these approaches are limited by both design complexity and inefficient, costineffective operation. The discovery of CRISPR/Cas9, a branch of the bacterial adaptive immune system, as a potential genomic editing tool holds the promise of facile targeted cleavage. Its novelty lies in its RNA-guided endonuclease activity, which enhances its efficiency, scalability, and ease of use. The only necessary components are a Cas9 endonuclease protein and an RNA molecule tailored to the gene of interest. This lowbarrier of adoption has facilitated a plethora of advances in just the past three years since its discovery. In this review, we will discuss the impact of CRISPR/Cas9 on biomedical research and its potential implications in medicine.


Subject(s)
Biomedical Research/methods , CRISPR-Cas Systems/genetics , Gene Editing/methods , Genomics/methods , Medicine/methods , Animals , Genetic Therapy , Humans
12.
Eur J Cancer ; 48(18): 3414-21, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22835781

ABSTRACT

OBJECTIVE: The purpose of this study is to investigate the diagnostic accuracy of 3.0Tesla (3T) diffusion-weighted magnetic resonance imaging (MRI) in addition to conventional MRI for the detection of lymphadenopathy in patients with early stage cervical cancer compared to histopathological evaluation of the systematically removed pelvic lymph nodes as reference standard. METHODS: 68 fédération internationale de gynécologie obstétrique (FIGO) stage Ia2 to IIb cervical cancer patients were included. Sensitivity and specificity rates for two experienced observers were computed for the detection of lymphatic metastasis. Reproducibility of conventional MRI was tested by kappa statistics. The variables included in the analysis were: size of the long axis, short axis, ratio short to long axis and apparent diffusion coefficient (ADC). RESULTS: Nine patients had 15 positive pelvic nodes at histopathological examination. The sensitivity and specificity of lymphatic metastasis detection by predefined conventional MRI characteristics was 33% (95% Confidence Interval (CI) 3-64) and 83% (95% CI 74-93) on patient level, and 33% (95% CI 7-60) and 97% (95% CI 95-99) on regional level respectively for observer 1. For observer 2 the sensitivity was 33% (95% CI 3-64) and the specificity 93% (95% CI 87-100) on patient level, and 25% (95% CI 1-50) and 98% (95% CI 97-100) on regional level, respectively. The kappa-value for reproducibility of metastasis detection on regional level was 0.50. The short axis diameter showed the highest diagnostic accuracy (area under the curve (AUC)=0.81 95% CI 0.70-0.91); ADC did not improve diagnostic accuracy (AUC=0.83 95% CI 0.73-0.93). CONCLUSIONS: Diffusion-weighted MRI did not result in additional diagnostic value compared to conventional MRI.


Subject(s)
Adenocarcinoma/secondary , Carcinoma, Squamous Cell/secondary , Diffusion Magnetic Resonance Imaging/methods , Lymphatic Metastasis/diagnosis , Neoplasm Staging/methods , Uterine Cervical Neoplasms/pathology , Adenocarcinoma/surgery , Adenocarcinoma, Clear Cell/secondary , Adenocarcinoma, Clear Cell/surgery , Adult , Aged , Carcinoma, Adenosquamous/secondary , Carcinoma, Adenosquamous/surgery , Carcinoma, Squamous Cell/surgery , Confidence Intervals , Female , Humans , Lymph Node Excision , Middle Aged , Observer Variation , Pelvis , Prospective Studies , ROC Curve , Reproducibility of Results , Sensitivity and Specificity , Uterine Cervical Neoplasms/surgery , Young Adult
13.
Hum Reprod ; 27(1): 153-8, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22025228

ABSTRACT

BACKGROUND: Chronic endometritis is associated with abnormal uterine bleeding, recurrent abortion and infertility. It is a subtle condition, and therefore is difficult to diagnose. The diagnosis is ultimately based on the presence of plasma cells in the endometrial stroma on histopathological examination. Literature on the reproducibility of the diagnosis of chronic endometritis is lacking. Therefore, the aim of the current study was to assess the interobserver agreement of two pathologists in diagnosing chronic endometritis in asymptomatic, infertile patients. METHODS: In the context of a randomized controlled trial, an endometrial biopsy was taken during a screening hysteroscopy prior to IVF. All endometrial samples were independently examined by two pathologist. The slides diagnosed with chronic endometritis were replenished with a random sample of the remaining slides up to a total of 100, then exchanged between the two pathologists and reassessed. RESULTS: Of the 678 patients who underwent hysteroscopy, 19 patients were diagnosed with at least possible chronic endometritis (2.8%). Perfect agreement between the pathologists, before and after inclusion of 13 slides with additional immunohistochemistry staining, was found in 88 and 86% of reviews, respectively. The interobserver agreement was substantial, with kappa-values of 0.55 and 0.66, respectively. CONCLUSIONS: The interobserver agreement in diagnosing chronic endometritis in asymptomatic infertile patients was found to be substantial. Although the diagnostic reliability is sufficient with the methods in the present study, the low prevalence and unknown clinical significance of endometritis warrants further study.


Subject(s)
Endometritis/diagnosis , Fertilization in Vitro/methods , Adult , Biopsy/methods , Chronic Disease , Endometritis/pathology , Endometrium/pathology , Female , Gynecology/methods , Humans , Hysteroscopy/methods , Immunohistochemistry/methods , Observer Variation , Pathology/methods , Prevalence , Reproducibility of Results
14.
J Clin Pathol ; 61(1): 36-42, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17483252

ABSTRACT

BACKGROUND: Derailments of the control mechanisms of the cell cycle can initiate carcinogenesis, and play a role in progression to cancer. AIM: To explore the expression of cell cycle proteins in normal, premalignant and malignant endometrial lesions representing the morphologically well defined stepwise model of human endometrial carcinogenesis METHODS: Observational study. Paraffin-embedded specimens from inactive endometrium (n = 16), endometrial hyperplasia (n = 23) and endometrioid endometrial carcinoma (n = 39) were stained immunohistochemically for cyclin A, cyclin B1, cyclin D1, cyclin E, cdk2, p16, p21, p27, p53 and Ki67(MIB-1)). Differences in expression between the tissues, and correlation with classical prognostic factors for the carcinomas were analysed. RESULTS: Expression of cyclin A and Ki67 gradually increased from normal through hyperplasia to carcinoma, indicating that proliferation increases over the carcinogenetic spectrum. cdk2, p16 and p21 gradually increased from normal through hyperplasia to carcinoma, indicating their potential importance in both early and late carcinogenesis. Cyclin D1, cyclin E and p53 especially increased and p27 decreased from hyperplasia to carcinoma, underlining their role in late carcinogenesis. In cancers, expression of cyclin A, p53 and Ki67 was positively correlated to grade, and cyclin A was positively correlated with cdk2, p21, Ki67, cyclin E and p53. CONCLUSION: During (endometrioid) endometrial carcinogenesis, there is increasing proliferation paralleled by progressive derailment of cyclin B1, cyclin D1, cyclin E, p16, p21, p27, p53, and cdk2, indicating the importance of these cell cycle regulators in endometrial carcinogenesis.


Subject(s)
Cell Cycle Proteins/metabolism , Cell Transformation, Neoplastic/metabolism , Endometrial Neoplasms/metabolism , Neoplasm Proteins/metabolism , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Adult , Aged , Aged, 80 and over , Cell Proliferation , Cell Transformation, Neoplastic/pathology , Disease Progression , Endometrial Neoplasms/pathology , Endometrium/metabolism , Endometrium/pathology , Female , Humans , Hyperplasia/metabolism , Hyperplasia/pathology , Middle Aged , Neoplasm Staging , Precancerous Conditions/metabolism , Precancerous Conditions/pathology
15.
Cell Oncol ; 29(1): 37-45, 2007.
Article in English | MEDLINE | ID: mdl-17429140

ABSTRACT

BACKGROUND: Cell cycle proteins and HIF-1alpha with downstream factors are often abberrantly expressed in (pre)neoplastic tissue. METHODS: Paraffin-embedded specimens of inactive endometrium with TM (n=15), ovarian inclusion cysts (n=6), cervix with TM (tubal metaplasia) (n=3), Fallopian tubes (n=7), cycling endometrium (n=9) and a ciliated cell tumor of the ovary were stained for p16 and LhS28. 39 Endometrioid endometrial carcinomas and 5 serous endometrial carcinomas were stained for p16. Additionally, inactive endometrium (n=15) was immunohistochemically stained for p21, p27, p53, cyclin A, cyclin D1, cyclin E, HIF-1alpha, CAIX, Glut-1 and MIB-1. RESULTS: A mosaic pattern of expression of p16 was seen throughout in all cases of endometrial TM (15/15), in 2/6 of the ovarian inclusion cysts with TM, in all (3/3) cervical TM and focal in 5/7 of Fallopian tube cases. Mosaic expression was also seen in a ciliated cell tumor of the ovary and in 18/39 of endometrioid endometrial carcinomas, and diffuse p16 expression was seen in 5/5 serous carcinomas. In comparison with normal endometrium, TM areas in the endometrium showed significantly increased expression of HIF-1alpha, cyclin E, p21 and cyclin A, and decreased expression of p27. Membranous expression of CAIX and Glut-1 was only seen in TM areas, pointing to functional HIF-1alpha. CONCLUSION: As p16 is consistently expressed in TM, less and only patchy expressed in the normal Fallopian tube, is paralleled by aberrant expression of cell cycle proteins, HIF-1alpha, CAIX and Glut-1 and resembles the pattern of p16 expression frequently seen in endometrial carcinomas, we propose endometrial TM to be a potential premalignant endometrial lesion.


Subject(s)
Cyclin-Dependent Kinase Inhibitor p16/analysis , Endometrium/pathology , Fallopian Tubes/pathology , Carcinoma, Endometrioid/metabolism , Carcinoma, Endometrioid/pathology , Cervix Uteri/chemistry , Cervix Uteri/pathology , Cyclin A/analysis , Cyclin D1/analysis , Cyclin E/analysis , Cyclin-Dependent Kinase Inhibitor p21/analysis , Cyclin-Dependent Kinase Inhibitor p27/analysis , Cyclin-Dependent Kinase Inhibitor p27/metabolism , Endometrial Neoplasms/metabolism , Endometrial Neoplasms/pathology , Endometrium/chemistry , Fallopian Tubes/chemistry , Female , Glucose Transporter Type 1/analysis , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/analysis , Immunohistochemistry , Metaplasia
16.
Int J Gynecol Cancer ; 17(2): 517-20, 2007.
Article in English | MEDLINE | ID: mdl-17316354

ABSTRACT

Stage IA vulvar carcinoma is not supposed to metastasize to the lymph nodes. Therefore, it is assumed that these lesions can be safely treated by less aggressive methods than macroinvasive carcinomas. However, in this case report, two patients are described who had vulvar lesions with a depth of invasion of less than 1 mm and developed lymph node metastases in the groin despite radical wide local excision of their lesions. Both the patients underwent lymphadenectomy and received postoperative radiation therapy on the groins. Neither of the two patients died of vulvar carcinoma. Thus, we conclude that vigilance for the occurrence of lymph node metastases remains necessary after radical, local excision in stage IA vulvar cancer. However, this case report also shows that adequate treatment of groin node metastases can result in a very good long-term survival.


Subject(s)
Carcinoma/pathology , Lymphatic Metastasis , Vulvar Neoplasms/pathology , Aged, 80 and over , Female , Humans , Lymph Node Excision , Middle Aged , Recurrence
17.
Int J Gynecol Cancer ; 16(1): 231-9, 2006.
Article in English | MEDLINE | ID: mdl-16445638

ABSTRACT

Human ovarian cancers are thought to arise from sequestered ovarian surface epithelial (OSE) cells that line the wall of inclusion cysts. Nevertheless, the early events toward neoplasia are not well understood. In this study, immunoreactivity for apoptotic proteins in human OSE of control and tumor ovarian sections was examined. Ki67, a marker for cell proliferation, was generally absent in the flat-to-cuboidal OSE cells on the ovarian surface and in regularly shaped inclusion cysts. Fas, Fas ligand, and caspase-3, components of the apoptotic pathway, were also largely absent. Ki67, Fas, Fas ligand, and procaspase-3 expression, though not active caspase-3 expression, was more frequently observed in epithelial cells lining irregularly shaped inclusion cysts, particularly in the columnar and Müllerian-like OSE cell types that resembled ovarian tumor OSE cells. Immunoreactivity for these factors as well as active caspase-3 was found frequently in ovarian tumors. We postulate that the appearance of the Fas system and its related proteins in sequestered columnar OSE cells of irregularly shaped inclusion cysts may contribute to balance cell growth with cell death, although little active caspase-3 expression was observed. Further studies are required to identify whether inhibition of apoptosis in inclusion cysts is an early event in ovarian carcinogenesis.


Subject(s)
Biomarkers, Tumor/analysis , Ovarian Cysts/pathology , Ovarian Neoplasms/pathology , Ovary/cytology , Adult , Aged , Aged, 80 and over , Analysis of Variance , Case-Control Studies , Caspase 3 , Caspases/genetics , Cell Proliferation , Diagnosis, Differential , Female , Humans , Immunohistochemistry , Ki-67 Antigen/genetics , Middle Aged , Ovarian Cysts/genetics , Ovarian Neoplasms/surgery , Ovariectomy , Ovary/pathology , Probability , Prognosis , Reference Values , Sampling Studies , Sensitivity and Specificity , Tissue Culture Techniques , fas Receptor/genetics
18.
B-ENT ; 2(4): 189-92, 2006.
Article in English | MEDLINE | ID: mdl-17256407

ABSTRACT

About 70 to 80 percent of all salivary gland neoplasms, the majority of which are benign, arise in the parotid gland. Sclerosing Polycystic Adenosis (SPA) is a relatively unknown and newly described entity that is considered to be benign in nature. A 55-year-old patient was treated for SPA in our hospital. The diagnostic work-up consisted of Magnetic Resonance Imaging (MRI), Fine Needle Aspiration Cytology (FNAC) and histological examination. However, in our case, both the cytological appearance, which usually has a high accuracy in discriminating benign from malignant lesions, and the appearance on MR images, mimicked a malignant tumour. This case report illustrates the importance of an adequate histological confirmation of the work-up diagnosis.


Subject(s)
Cysts/diagnosis , Parotid Diseases/diagnosis , Parotid Gland/pathology , Biopsy, Fine-Needle , Cysts/surgery , Diagnosis, Differential , Fibrosis/pathology , Humans , Hyperplasia/pathology , Male , Middle Aged , Parotid Diseases/pathology , Parotid Diseases/surgery , Treatment Outcome
20.
Clin Exp Dermatol ; 26(2): 173-5, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11298109

ABSTRACT

We describe a 16-year-old Filipino boy who presented with skin lesions highly suggestive of lepromatous leprosy, but further assessment established a diagnosis of malignant T-cell lymphoma. This case emphasizes the extensive differential diagnosis of leprosy, as well as the importance of obtaining skin biopsies for diagnostic confirmation.


Subject(s)
Leprosy, Lepromatous/diagnosis , Lymphoma, T-Cell/diagnosis , Skin Neoplasms/diagnosis , Adolescent , Biopsy , Diagnosis, Differential , Humans , Male , Skin Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...